MBC BioLabs Announces New Partnership with Twist Bioscience

[San Francisco, CA – June 2, 2025] – MBC BioLabs is proud to announce it has entered into a partnership with Twist Bioscience. This partnership will help support the mission of enabling awesome for MBC BioLabs’ community of high-growth biotech start-up companies.

We invite you to join us at noon in the MBC BioLabs campus at 953 Indiana Ave in San Francisco on June 3 or 930 Brittan Ave on June 5 for a celebration and launch of this exciting partnership.

Registration required: June 3 @ 953 Indiana St / June 5 @ 930 Brittan Ave

About Twist Bioscience
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

About MBC BioLabs
At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like-minded individuals tackling the world’s biggest problems.

We have helped launch and grow over 400 companies since opening in October of 2013, and together, MBC companies have initiated 176 clinical trials, introduced 135 products to market, and collectively raised over $20 billion. Learn more at mbcbiolabs.com.